• 1. Self-sufficient asymmetric reduction of β-ketoesters catalysed by a novel and robust thermophilic alcohol dehydrogenase co-immobilised with NADH
  Alejandro H. Orrego,Daniel Andrés-Sanz,Susana Velasco-Lozano,Mercedes Sanchez-Costa,José Berenguer,José M. Guisan,Javier Rocha-Martin,Fernando López-Gallego Catal. Sci. Technol. 2021 11 3217
• 2. Stereospecific synthesis of a chiral intermediate for the preparation of thienamycin, penems, and carbapenems: use of the nitro group as a hydroxy protecting group
  Gianfranco Cainelli,Mauro Panunzio,Tiziana Basile,Alessandro Bongini,Daria Giacomini,Giorgio Martelli J. Chem. Soc. Perkin Trans. 1 1987 2637
• 3. Stereo- and enantio-controlled synthesis of chiral intermediates for the total synthesis of thienamycin and related β-lactam antibiotics from 3-hydroxybutyrates
  Gunda I. Georg,Harpal S. Gill J. Chem. Soc. Chem. Commun. 1985 1433
• 4. Synthesis of the fungus metabolite cladosin C
  David Linder,Rainer Schobert Org. Biomol. Chem. 2017 15 7672
• 5. Glycerol and derived solvents: new sustainable reaction media for organic synthesis
  Alba E. Díaz-álvarez,Javier Francos,Beatriz Lastra-Barreira,Pascale Crochet,Victorio Cadierno Chem. Commun. 2011 47 6208

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Hydroxy acids and derivatives Beta hydroxy acids and derivatives

Ethyl (S)-3-hydroxybutyrate (CAS No. 56816-01-4): A Key Intermediate in Modern Chemical and Pharmaceutical Applications

Ethyl (S)-3-hydroxybutyrate, identified by the chemical compound code CAS No. 56816-01-4, is a significant intermediate in the realm of chemical synthesis and pharmaceutical development. This compound, characterized by its chiral center, has garnered considerable attention due to its versatile applications in various biochemical pathways and synthetic processes.

The molecular structure of Ethyl (S)-3-hydroxybutyrate consists of a hydroxy group and an ethyl ester moiety attached to a butyric acid backbone. This unique configuration makes it a valuable building block for the synthesis of more complex molecules, particularly in the pharmaceutical industry. The presence of the (S)-configuration at the chiral center enhances its utility in creating enantiomerically pure compounds, which are often required for drug development to ensure optimal efficacy and minimal side effects.

In recent years, Ethyl (S)-3-hydroxybutyrate has been extensively studied for its role in metabolic pathways and its potential therapeutic applications. Research has demonstrated that this compound can serve as a precursor for various bioactive molecules, including those involved in energy metabolism and neurotransmitter synthesis. Its ability to modulate these pathways has opened new avenues for treating metabolic disorders and neurological conditions.

One of the most notable applications of Ethyl (S)-3-hydroxybutyrate is in the field of metabolic research. Studies have shown that it can be converted into other important metabolites, such as β-hydroxybutyric acid, which plays a crucial role in ketone body metabolism. This conversion process is particularly relevant in conditions where energy production needs to be optimized, such as during fasting or intense physical activity.

The pharmaceutical industry has also explored the use of Ethyl (S)-3-hydroxybutyrate as a starting material for synthesizing novel drug candidates. Its chiral nature allows for the production of enantiomerically pure drugs, which are often more effective and safer than their racemic counterparts. For instance, researchers have investigated its potential use in developing treatments for neurological disorders, where the precise stereochemistry of drugs is critical.

Moreover, Ethyl (S)-3-hydroxybutyrate has shown promise in the area of synthetic organic chemistry. Its reactivity with various functional groups makes it a valuable tool for constructing complex molecular frameworks. Chemists have utilized this compound to develop novel synthetic routes for heterocyclic compounds, which are widely used in pharmaceuticals and agrochemicals.

The production of Ethyl (S)-3-hydroxybutyrate has also seen advancements due to modern biotechnological techniques. Fermentation processes using engineered microorganisms have enabled the efficient synthesis of this compound on an industrial scale. These biotechnological approaches not only improve yield but also make the production process more environmentally sustainable compared to traditional chemical synthesis methods.

In conclusion, Ethyl (S)-3-hydroxybutyrate (CAS No. 56816-01-4) is a multifaceted compound with significant implications in both chemical synthesis and pharmaceutical applications. Its role as an intermediate in metabolic pathways and its potential use in drug development underscore its importance in modern science. As research continues to uncover new applications for this compound, its relevance is expected to grow further, making it a cornerstone in future advancements.

• 24915-95-5(Ethyl (R)-3-hydroxybutyrate)
• 32328-03-3(Diethyl 3-hydroxyglutarate)
• 61597-99-7(Butanoic acid, 3-hydroxy-, butyl ester, (S)-)
• 112083-63-3(ethyl 2-(2S)-oxiran-2-ylacetate)
• 2305-25-1(Ethyl 3-hydroxyhexanoate)
• 53605-94-0(Butanoic acid, 3-hydroxy-, butyl ester)
• 151763-75-6(Tetradecanoic acid,3-hydroxy-, ethyl ester, (3R)-)
• 112083-64-4(ethyl 2-(2R)-oxiran-2-ylacetate)
• 139629-09-7(1,5,9-Trioxacyclododecane-2,6,10-trione, 4,8,12-trimethyl-, (4S,8S,12S)-)
• 5405-41-4(Ethyl 3-hydroxybutyrate)